Home
This Title All WIREs
WIREs RSS Feed
How to cite this WIREs title:
WIREs Nanomed Nanobiotechnol
Impact Factor: 7.689

Dendrimers—revolutionary drugs for infectious diseases

Full article on Wiley Online Library:   HTML PDF

Can't access this content? Tell your librarian.

Abstract Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease

This WIREs title offers downloadable PowerPoint presentations of figures for non-profit, educational use, provided the content is not modified and full credit is given to the author and publication.

Download a PowerPoint presentation of all images


Polyamidoamine (PAMAM) G3 as a representation of a typical dendrimer structure.

[ Normal View | Magnified View ]

New antibacterial G1 dendrimers possessing tris‐amino acids (a) or tetrakis‐amino alcohols (b) as core compounds.

[ Normal View | Magnified View ]

Trifunctional and hexafunctional‐cored phosphorus dendrimers surface‐modified with an analogue of natural galactosylceramide (GalCer).

[ Normal View | Magnified View ]

The chemical structure of SPL7013 dendrimer.

[ Normal View | Magnified View ]

Schematic representation of fan, ball, and dumbbell‐shaped carbosilane dendrimers.

[ Normal View | Magnified View ]

Strategies of inhibition of viral and bacterial infections using dendrimers. The invasion of the cell by viruses can be prevented by dendrimers which coat viral envelope receptors and thereby make interactions with the host cell impossible. Another mechanism consists in the blockage of host cell receptors by dendrimers which precludes attachment of viral particles to this cell. The inhibition of bacterial (and also fungal) infections is based on electrostatic interactions between positively charged groups of dendrimers and the negatively charged bacterial (or fungal) membrane which results in its disintegration and release of cell content. C, capsule; CM, cell membrane; CW, cell wall; D, dendrimer; V, virus.

[ Normal View | Magnified View ]

Chemical structure of N‐acetylneuraminic (sialic) acid.

[ Normal View | Magnified View ]

Chemical structure of the phosphorus dendrimer G2.

[ Normal View | Magnified View ]

Chemical structure of the carbosilane dendrimer G3.

[ Normal View | Magnified View ]

Chemical structure of the poly‐l‐lysine dendrimer G3.

[ Normal View | Magnified View ]

Chemical structure of the polypropyleneimine dendrimer G3.

[ Normal View | Magnified View ]

Related Articles

Bacteria: An Interdisciplinary View
Therapeutics: An Interdisciplinary View

Browse by Topic

Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease

Access to this WIREs title is by subscription only.

Recommend to Your
Librarian Now!

The latest WIREs articles in your inbox

Sign Up for Article Alerts